FDA Adverse Event Injury Summary report: N

ASR UNI FEMORAL IMPL SIZE 41

MDR report key: 2983769 · Received February 28, 2013

Report

Report Number
1818910-2013-01770
Event Type
Injury
Date Received
February 28, 2013
Report Date
December 17, 2013
Manufacturer
DEPUY INTERNATIONAL
Product Code
KWA
PMA / PMN Number
K040627
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Additional Manufacturer Narrative · 1

DEPUY STILL CONSIDERS THIS INVESTIGATION CLOSED.

Additional Manufacturer Narrative · 1

DEPUY STILL CONSIDERS THIS INVESTIGATION CLOSED.

Description of Event or Problem · 1

**UPDATE** (B)(4) 2013 - THE SALES REP HAS REPORTED THE REVISION SURGERY. PATIENT WAS REVISED TO ADDRESS ELEVATED COBALT AND CHROMIUM LEVELS.

Description of Event or Problem · 1

**UPDATE** (B)(4) 2013 - MEDICAL RECORDS WERE OBTAINED. MEDICAL RECORDS INDICATE PATIENT WAS REVISED DUE TO PSEUDOTUMOR AND METALLOSIS STAINED TISSUE. THE INFORMATION RECEIVED DOES NOT CHANGE THE MDR DECISION. THE COMPLAINT WAS UPDATED ON: (B)(4) 2013.

Description of Event or Problem · 1

LITIGATION PAPERS ALLEGE THE PATIENT SUFFERED PAIN AND SUFFERING AND EMOTIONAL DISTRESS AND SHE WAS INJURED BY EXCESSIVE LEVELS OF CHROMIUM AND COBALT IN HER BLOOD AS A RESULT OF IMPLANTATION OF THE DEPUY ASR HIP IMPLANT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
87928 ASR UNI FEMORAL IMPL SIZE 41 FEMORAL HEAD HIP IMPLANT KWA DEPUY INTERNATIONAL 2484006

Patients

Seq Age Sex Outcome Treatment
1 Other